Cannabis Abstinence and Neurocognitive Assessment in Adolescence

Conditions: Cannabis Dependence, Harmful Use, Cognitive Assessment

Sex: All

Ages: 15 Years – 18 Years

Healthy volunteers: No

Enrollment: 29

Sponsor: University Hospital Pilsen

Location: University Hospital Pilsen Pilsen Czechia

Summary

Cannabis Abstinence and Neurocognitive Assessment in Adolescence

Eligibility Criteria

Inclusion Criteria: * Adolescents aged 15-18 years with a diagnosis of cannabis dependence or harmful cannabis use. Exclusion Criteria: * psychiatric comorbidity - Dual diagnosis, including psychotic disorders, mood disorders, severe organic brain damage, or autism spectrum disorder, with the exception of compensated and stabilized anxiety disorder. Psychopharmacological treatment is permitted, except for antipsychotics prescribed for psychosis. * somatic comorbidity - Severe endocrine disorders such as diabetes mellitus, thyroid dysfunction, or severe cardiovascular disease. * Violation of abstinence between the first and second neuropsychological assessments, as well as severe decompensation of mental state requiring modification of established psychopharmacological treatment.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07160153). StuddyBuddy aggregates publicly available trial information.